Akums Drugs and Pharmaceuticals Ltd 2025 Integrated Report
Company: Akums Drugs and Pharmaceuticals Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Integrated Report
Pages: 343
The report presents Akums' first Integrated Report and describes the successful FY25 IPO alongside consolidated revenue of INR 4,118.20 Crores. It reports renewable energy share of 33.70% and total Scope 3 emissions of 1,76,304.32 Metric tonnes of CO2 equivalent across four categories. The report also details a Double Materiality Assessment covering 38 ESG topics.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.